Viewing Study NCT06855160


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-02-09 @ 8:45 AM
Study NCT ID: NCT06855160
Status: RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-02-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age
Sponsor: GlaxoSmithKline
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chickenpox View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chicken pox View
None Candidate l varicella vaccine (VNS) View
None Varicella View
None Varivax View
None Healthy Children View